GWS
FLGT icon

Glassman Wealth Services’s Fulgent Genetics FLGT Stock Holding History

Glassman Wealth Services’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-13
Closed -$376 – 778
2023
Q4 		$376 Buy
+13
New +$348 ﹤0.01% 1771
2023
Q2 		– Sell
-16
Closed -$500 – 1945
2023
Q1 		$500 Buy
+16
New +$515 ﹤0.01% 1616
2022
Q3 		– Sell
-4
Closed – – 1766
2022
Q2 		$0 Buy
+4
New +$220 ﹤0.01% 1779
2020
Q3 		– Sell
-1,000
Closed -$16K – 1376
2020
Q2 		$16K Buy
+1,000
New +$15.3K 0.01% 414

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Glassman Wealth Services's FLGT Position: Q1 2024 in Review

Glassman Wealth Services sold out of Fulgent Genetics (FLGT) in Q1 2024, closing a stake of 13 shares — an estimated $376 sold.

Glassman Wealth Services first reported a position in FLGT in Q2 2020 and held it in 4 quarters. The position peaked at $16K in Q2 2020. 180 funds tracked by Wall St. Rank hold FLGT as of Q1 2024.

  • Glassman Wealth Services reported no remaining Fulgent Genetics position as of Q1 2024 after selling out during the quarter.
  • Glassman Wealth Services sold 13 Fulgent Genetics shares in Q1 2024, an estimated $376.
  • Glassman Wealth Services first reported a position in Fulgent Genetics in Q2 2020 and held it in 4 quarters.
  • Glassman Wealth Services's Fulgent Genetics position peaked at $16K in Q2 2020.
  • 180 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.